Robert Carlisle, MD
Orthopaedic Surgery · Sandusky, OHNPI 1225410905
Payments from drug & device makers
Across 86 payments — averaging $307.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$15K
- Zimmer Biomet$6K
- Peerless Surgical Inc.$2K
- ALON Medical Technology$1K
- Medical Device Business Services, Inc.$1K
- Biotissue Holdings Inc.$402
- plus $549 from 9 others
What the payments were for
- Consulting fees$2,1258%
- Travel & lodging$2,74310%
- Food & beverage$3,39313%
- Education$18,22369%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $15,014 |
| Zimmer Biomet | 41 | $6,044 |
| Peerless Surgical Inc. | 3 | $1,987 |
| ALON Medical Technology | 1 | $1,260 |
| Medical Device Business Services, Inc. | 10 | $1,228 |
| Biotissue Holdings Inc. | 2 | $402 |
| Neurocrine Biosciences, Inc. | 16 | $258 |
| Hydrocision, Inc. | 1 | $77 |
| Rock Medical Orthopedics, Inc. | 1 | $55 |
| Pacira Pharmaceuticals Incorporated | 2 | $44 |
| Vertex | 2 | $31 |
| Davol Inc. | 1 | $25 |
| Hospira, Inc. | 1 | $23 |
| Stryker | 1 | $18 |
| Vericel Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$2,647
- Arcos$1,140
- ACTIS$1,062
- ATTUNE$1,062
- Persona$542
- TAPESTRY$446
- Affixus$323
- Z1 HIP SYSTEM$299
- Taperloc$200
- ORTHOGRID HIP$147
- AccuFill$144
- ROSA-Knee$123
- HAMMR CURVED G7 IMPACTOR$118
- mymobility Platform$104
How this compares
$26,485 in reported general payments places this provider in the 80th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 16 | $10,162 |
| Diclofenac Sodium | 170 | $2,923 |
| Celecoxib | 84 | $1,261 |
| Meloxicam | 343 | $889 |
| Oxycodone Hcl | 182 | $681 |
| Cefadroxil | 121 | $651 |
| Methylprednisolone | 53 | $355 |
| Tramadol Hcl | 189 | $308 |
| Pantoprazole Sodium | 77 | $199 |
| Doxycycline Hyclate | 20 | $173 |
| Ondansetron Hcl | 125 | $149 |
| Amoxicillin | 149 | $137 |
| Prednisone | 84 | $82 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 11 | $76 |
| Ibuprofen | 14 | $60 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Sandusky
- Reuben GobezieCleveland$12.6M
- Brad PichaIndependence$12.3M
- Gregory BerletWorthington$9.9M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.9M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- Mark FroimsonCleveland$2.9M
- David WelkerMiamisburg$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.